This study examined support for the human papillomavirus (HPV) vaccine among a representative sample of Minnesota parents after approval from the U.S. Food and Drug Administration. Support for the vaccine was high; 87% supported its use. Although individual characteristics predicted support, support was high across subgroups with two-thirds or more of parents supporting the vaccine.
Bibliographical noteFunding Information:
The authors thank Karen Virnig and Todd Rockwood for their contributions to the study. This research was supported by the Irvine McQuarrie Research Scholar Award at the University of Minnesota and by Cooperative Agreement Number U48/DP000063 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.
- Human papillomavirus